PHARMACEUTICAL COMPOSITION FOR TREATING ASTHENIA AND/OR CHRONIC FATIGUE SYNDROME

摘要

FIELD: medicine.SUBSTANCE: pharmaceutical composition for correction of clinical symptoms asthenia and/or chronic fatigue syndrome both separately and in various diseases and/or pre-and/or postmorbid states in mammals, characterised by that as active ingredients it contains 2-ethylthiobenzimidazole hydrobromide and/or its pharmaceutically acceptable salt and carnitine in therapeutically effective amounts.EFFECT: composition can be used for treating various conditions associated with insufficient energy potential, which is a result of pathological process.4 cl, 15 tbl, 3 dwg, 4 ex